Literature DB >> 10668674

Rationale for elective neck dissection.

K T Pitman1.   

Abstract

Mesh：

Year:  2000        PMID： 10668674     DOI： 10.1016/s0196-0709(00)80121-0

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN： 0196-0709            Impact factor:   1.808


× No keyword cloud information.
  20 in total

1.  Impact of lymph node sampling on survival in cN0 major salivary gland adenoid cystic carcinoma.

Authors:  Zhen Jason Qian; Michelle M Chen; Vasu Divi; Uchechukwu C Megwalu
Journal:  Head Neck       Date:  2019-01-08       Impact factor: 3.147

2.  Incidence of cervical lymph node metastasis and its association with outcomes in patients with adenoid cystic carcinoma. An international collaborative study.

Authors:  Moran Amit; Yoav Binenbaum; Kanika Sharma; Naomi Ramer; Ilana Ramer; Abib Agbetoba; Joelle Glick; Xinjie Yang; Delin Lei; Kristine Bjørndal; Christian Godballe; Thomas Mücke; Klaus-Dietrich Wolff; Dan Fliss; André M Eckardt; Chiara Copelli; Enrico Sesenna; Frank Palmer; Ian Ganly; Snehal Patel; Ziv Gil
Journal:  Head Neck       Date:  2014-07-24       Impact factor: 3.147

Review 3.  Cancer of the gingiva.

Authors:  Rusana Bark; Claes Mercke; Eva Munck-Wikland; Natalie Ann Wisniewski; Lalle Hammarstedt-Nordenvall
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-04       Impact factor: 2.503

Review 4.  Prognostic biological features in neck dissection specimens.

Authors:  Julia A Woolgar; Asterios Triantafyllou; James S Lewis; Jennifer Hunt; Michelle D Williams; Robert P Takes; Lester D R Thompson; Pieter J Slootweg; Kenneth O Devaney; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-09-15       Impact factor: 2.503

Review 5.  Superselective neck dissection: rationale, indications, and results.

Authors:  Carlos Suárez; Juan P Rodrigo; K Thomas Robbins; Vinidh Paleri; Carl E Silver; Alessandra Rinaldo; Jesus E Medina; Marc Hamoir; Alvaro Sanabria; Vanni Mondin; Robert P Takes; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-01-16       Impact factor: 2.503

Review 6.  Outcome after elective neck dissection and observation for the treatment of the clinically node-negative neck (cN0) in squamous cell carcinoma of the oropharynx.

Authors:  R Böscke; B D Cakir; A S Hoffmann; S Wiegand; J Quetz; J E Meyer
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-05-10       Impact factor: 2.503

7.  Frequency of bilateral cervical metastases in hypopharyngeal squamous cell carcinoma: a retrospective analysis of 203 cases after bilateral neck dissection.

Authors:  Bernhard Olzowy; Matthias Hillebrand; Ulrich Harréus
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-08-24       Impact factor: 2.503

Review 8.  The Latest Advancements in Selective Neck Dissection for Early Stage Oral Squamous Cell Carcinoma.

Authors:  Zong-Shan Shen; Jin-Song Li; Wei-Liang Chen; Song Fan
Journal:  Curr Treat Options Oncol       Date:  2017-05

9.  Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma.

Authors:  L W T Alkureishi; Z Burak; J A Alvarez; J Ballinger; A Bilde; A J Britten; L Calabrese; C Chiesa; A Chiti; R de Bree; H W Gray; K Hunter; A F Kovacs; M Lassmann; C R Leemans; G Mamelle; M McGurk; J Mortensen; T Poli; T Shoaib; P Sloan; J A Sorensen; S J Stoeckli; J B Thomsen; G Trifiro; J Werner; G L Ross
Journal:  Ann Surg Oncol       Date:  2009-11       Impact factor: 5.344

10.  Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma.

Authors:  Lee W T Alkureishi; Zeynep Burak; Julio A Alvarez; James Ballinger; Anders Bilde; Alan J Britten; Luca Calabrese; Carlo Chiesa; Arturo Chiti; Remco de Bree; Harry W Gray; Keith Hunter; Adorjan F Kovacs; Michael Lassmann; C Rene Leemans; Gerard Mamelle; Mark McGurk; Jann Mortensen; Tito Poli; Taimur Shoaib; Philip Sloan; Jens A Sorensen; Sandro J Stoeckli; Jorn B Thomsen; Giusepe Trifiro; Jochen Werner; Gary L Ross
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-11       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.